ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:
| 1. | Details of the person discharging managerial responsibility / person closely associated | ||
| a) | Name | Henrik Jacobi | |
| 2. | Reason for the notification | ||
| a) | Position/status | Member of the Board of Management | |
| b) | Initial notification/ amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | ALK-Abelló A/S | |
| b) | LEI | 529900SGCREUZCZ7P020 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares DK0060027142 | |
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 2,621 | 3,200 | ||
| d) | Aggregated information - Aggregated volume - Price | 3,200 DKK 8,388,170 | |
| e) | Date of the transaction | 2021-03-02 | |
| f) | Place of the transaction | Nasdaq Copenhagen | |
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, mobile +45 2261 2525
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Fluence7.11.2025 08:00:00 CET | Press release
LEAG and Fluence to build the largest battery storage project in Europe with a capacity of 4 GWh
Memo Therapeutics AG7.11.2025 08:00:00 CET | Press release
Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Re-source Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting
Sampo plc7.11.2025 07:30:00 CET | Press release
Sampo plc’s share buybacks 6 November 2025
Brunel International NV7.11.2025 07:30:00 CET | Press release
Brunel Q3 2025 results: Driving operational efficiency
Corbion7.11.2025 07:00:00 CET | Press release
Corbion signs a new debt issuance for USD 100 million in the US Private Placement market
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
